Miguel Ruiz De La Cruz

Dr. Miguel Ruiz De La Cruz

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
LMLaura Moreno-Altamirano
Laura Moreno-Altamirano
KRKarina Robles-Rivera
Karina Robles-Rivera
Hugo Gildardo Castelán-SánchezHugo Gildardo Castelán-Sánchez
Hugo Gildardo Castelán-Sánchez
FPFelipe Vaca Paniagua
Felipe Vaca Paniagua
Maria del Carmen IñarrituMaria del Carmen Iñarritu
Maria del Carmen Iñarritu
ANARMANDO NAVARRO
ARMANDO NAVARRO
The gut microbiota plays a vital role in various physical and physiological processes, including immune system regulation, neurotransmitter production, inflammatory response modulation, and the inhibition of pathogenic organisms. An imbalance in the microbial community, known as dysbiosis, has been associated with numerous health issues. Biological influences, health behaviors, socioeconomic determinants, and nutritional status can disrupt this balance. Objective: To evaluate the differences in the gut microbiota composition in medical students according to fiber intake, ultra-processed food (UPF) consumption, sex, body mass index, and socioeconomic status. Methods: A cross-sectional study was conducted with 91 medical students, and 82 fecal samples were analyzed. Sociodemographic and dietary data were collected via questionnaires, UPF consumption was assessed using the NOVA classification, and trained nutritionists performed anthropometry. DNA extraction and 16S rRNA sequencing were performed for the microbial analysis. Bioinformatics and statistical tests included the Dunn and Kruskal–Wallis tests, a PCoA analysis, PERMANOVA, ANOVA, Spearman’s rank correlation, and alpha and beta diversity metrics. Results: Dietary fiber intake strongly influences gut microbiota composition. Lower fiber intake was associated with a higher prevalence of Parabacteroides and Muribaculaceae. Prevotella was more prevalent in individuals with lower UPF intake, while Phascolarctobacterium was prevalent in those with higher UPF consumption. Significant differences were associated with sex and UPF consumption but not BMI or SES. Women consumed more UPF, which correlated with distinct gut microbiota profiles. Conclusions: This study highlights the significant impact of diet, particularly fiber intake and UPF, on gut microbiota composition, emphasizing the importance of dietary habits in maintaining gut health.

19 June 2024 in npj Precision Oncology
Verified
Journal Article
Open access
PDF file
MCMiguel Ruiz De La Cruz
Miguel Ruiz De La Cruz
HMHécTor MartínEz-Gregorio
HécTor MartínEz-Gregorio
CDClara Estela DíaZ-VelásQuez
Clara Estela DíaZ-VelásQuez
FAFernando Ambriz-Barrera
Fernando Ambriz-Barrera
NRNorma Gabriela Resendiz-Flores
Norma Gabriela Resendiz-Flores
FPFelipe Vaca Paniagua
Felipe Vaca Paniagua
Less than 15–20% of patients who meet the criteria for hereditary breast and ovarian cancer (HBOC) carry pathogenic coding genetic mutations, implying that other molecular mechanisms may contribute to the increased risk of this condition. DNA methylation in peripheral blood has been suggested as a potential epigenetic marker for the risk of breast cancer (BC). We aimed to discover methylation marks in peripheral blood associated with BC in 231 pre-treatment BC patients meeting HBOC criteria, testing negative for coding pathogenic variants, and 156 healthy controls, through methylation analysis by targeted bisulfite sequencing on 18 tumor suppressor gene promoters (330 CpG sites). We found i) hypermethylation in EPCAM (17 CpG sites; p = 0.017) and RAD51C (27 CpG sites; p = 0.048); ii) hypermethylation in 36 CpG-specific sites (FDR q < 0.05) in the BC patients; iii) four specific CpG sites were associated with a higher risk of BC (FDR q < 0.01, Bonferroni p < 0.001): cg89786999-FANCI (OR = 1.65; 95% CI:1.2–2.2), cg23652916-PALB2 (OR = 2.83; 95% CI:1.7–4.7), cg47630224-MSH2 (OR = 4.17; 95% CI:2.1–8.5), and cg47596828-EPCAM (OR = 1.84; 95% CI:1.5–2.3). Validation of cg47630224-MSH2 methylation in one Australian cohort showed an association with 3-fold increased BC risk (AUC: 0.929; 95% CI: 0.904–0.955). Our findings suggest that four DNA methylation CpG sites may be associated with a higher risk of BC, potentially serving as biomarkers in patients without detectable coding mutations.

26 September 2021 in Cancers
Verified
Journal Article
Open access
PDF file
MCMiguel Ruiz De La Cruz
Miguel Ruiz De La Cruz
Aldo H de la Cruz-MontoyaAldo H de la Cruz-Montoya
Aldo H de la Cruz-Montoya
ERErnesto Rojas-Jiménez
Ernesto Rojas-Jiménez
HGHéctor Martínez Gregorio
Héctor Martínez Gregorio
CVClara Estela Díaz Velásquez
Clara Estela Díaz Velásquez
FPFelipe Vaca Paniagua
Felipe Vaca Paniagua
Epigenetics affects gene expression and contributes to disease development by alterations known as epimutations. Hypermethylation that results in transcriptional silencing of tumor suppressor genes has been described in patients with hereditary cancers and without pathogenic variants in the coding region of cancer susceptibility genes. Although somatic promoter hypermethylation of these genes can occur in later stages of the carcinogenic process, constitutional methylation can be a crucial event during the first steps of tumorigenesis, accelerating tumor development. Primary epimutations originate independently of changes in the DNA sequence, while secondary epimutations are a consequence of a mutation in a cis or trans-acting factor. Secondary epimutations have a genetic basis in cis of the promoter regions of genes involved in familial cancers. This highlights epimutations as a novel carcinogenic mechanism whose contribution to human diseases is underestimated by the scarcity of the variants described. In this review, we provide an overview of secondary epimutations and present evidence of their impact on cancer. We propose the necessity for genetic screening of loci associated with secondary epimutations in familial cancer as part of prevention programs to improve molecular diagnosis, secondary prevention, and reduce the mortality of these diseases.

16 December 2022 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
JCJosé Alberto Carlos-Escalante
José Alberto Carlos-Escalante
SPSonia iliana Mejia Perez
Sonia iliana Mejia Perez
ESErnesto Soto-Reyes
Ernesto Soto-Reyes
LGLissania Guerra-Calderas
Lissania Guerra-Calderas
BCBernardo Cacho-Díaz
Bernardo Cacho-Díaz
TWTalia Wegman
Talia Wegman

2 July 2025 in Briefings in Bioinformatics
Verified
Journal Article
Open access
FAFernando Ambriz-Barrera
Fernando Ambriz-Barrera
MCMiguel Ruiz De La Cruz
Miguel Ruiz De La Cruz
HGHéctor Martínez Gregorio
Héctor Martínez Gregorio
CDClara E Díaz-Velásquez
Clara E Díaz-Velásquez
Aldo H de la Cruz-MontoyaAldo H de la Cruz-Montoya
Aldo H de la Cruz-Montoya
FPFelipe Vaca Paniagua
Felipe Vaca Paniagua
Motivation: Bisulfite sequencing (BS-Seq) enables a comprehensive and detailed analysis of DNA methylation patterns at single-nucleotide resolution. While methylation differences can contribute to various diseases, their sincronous occurrence at distinct loci complicates understanding. Therefore, advanced tools are essential to facilitate the identification and analysis of methylation programs and patterns. Results: AutoMethyc provides a comparative approach by integrating different algorithms coordinated and optimized for use on desktop computers and servers. The workflow evaluates the methylation status from different perspectives, facilitating interpretation in an interactive HTML report, incorporating new co-methylation analyses for marker identification, as well as exploratory complex workflows with dimension reduction techniques and identification of unsupervised groups between samples or sites. AutoMethyc was tested in a breast cancer study ($n=389$; 233 cases and 156 controls) using BS-Seq data from the Illumina MiSeq platform, mapping 330 methylation-prone citocine (CpG) sites in 20 genes. The analysis was performed on a desktop with 64 GB RAM, 16 cores (4.673 GHz), and 326 KB/s internet, running Fedora 39 with i3wm. The tool processed the dataset in 48 h, showcasing its efficiency and scalability.

Verified
Journal Article
Open access
PDF file
GPGloria Luz Paniagua-Contreras
Gloria Luz Paniagua-Contreras
ACAlan Cano-Kobayashi
Alan Cano-Kobayashi
AFAna Maria Fernández-Presas
Ana Maria Fernández-Presas
MCMiguel Ruiz De La Cruz
Miguel Ruiz De La Cruz
HGHéctor Martínez Gregorio
Héctor Martínez Gregorio
EMEric Monroy-Pérez
Eric Monroy-Pérez
C. albicans has recently been described as a secondary colonizer associated with periodontal infections. This study aimed to determine the expression patterns of ALS and SAP family genes in C. albicans strains isolated from patients with periodontal disease (n = 268), and a control group of healthy individuals without any clinical signs of periodontal disease (n = 100) was included. C. albicans and the ALS and SAP genes were identified using polymerase chain reaction (PCR). An in vitro infection model was used with the strains using the human gingival fibroblast cell line. RNA was extracted using a QIAcube robotic workstation (Qiagen). A QuantiTect Reverse Transcription Kit (Qiagen) was used for first-strand cDNA synthesis. ALS and SAP gene expression in the strains was determined using real-time PCR. A total of 82.5% (n = 66) of the C. albicans strains were isolated from patients with moderate periodontitis, 10% (n = 8) from patients with chronic periodontitis, and 7.5% (n = 6) from patients with gingivitis. In the group of healthy individuals, C. albicans was identified in 9% (9/100). Overall, the most frequently expressed ALS genes in the strains from the three diagnoses were ALS1 (77/80), ALS3 (67/80), ALS4 (67/80), ALS6 (77/80), ALS7 (62/80), and ALS9 (73/80), while the most frequently expressed SAP genes were SAP1 (76/80), SAP6 (57/80), SAP9 (78/80), and SAP10 (77/80). The overall frequencies of expression of the ALS4, ALS9, SAP2, SAP3, SAP6, and SAP genes in the strains were statistically different across the three diagnoses. We identified different profiles of expression of the ALS and SAP genes in the strains of C. albicans that contribute directly to the degree of periodontal disease. Therefore, our findings may contribute to improving our knowledge of the molecular mechanisms of C. albicans in the pathogenesis of periodontal disease.